Delivery Order SPE2DB22D1017-SPE2DB25FG0KA

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The contract has a ceiling value of $1,570.70 and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,129.80 and a period of performance ending on March 18, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The $1,100.15 firm fixed-price contract has an ultimate completion date of May 2, 2025 and is not designated as a set-aside. The contract represents a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a $1,622.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the procurement of Pfizer COVID-19 vaccines, with a period of performance from January 2024 to January 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $1,622.03 and is a firm fixed-price agreement. It is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 timeframe. The contract has a ceiling value of $1,129.80 and is a firm fixed-price type contract. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, with an ultimate completion date of February 18, 2025. The contract is designated as Firm Fixed Price and does not have a set-aside requirement. This delivery order...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,100.15 contract is for the delivery of Pfizer COVID-19 vaccine doses during the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has a performance period through May 9, 2025 and was awarded on April 18, 2025. This order is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The $1,570.70 firm fixed-price contract has an ultimate completion date of April 29, 2025 and is not set aside. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a $1,092.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical commodities. The award is part of a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG0KA
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,100.15 and a period of performance through May 8, 2025. It is not designated as a set-aside contract, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 2:30 PM